These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 1316082)

  • 1. Transgenic mice that develop pituitary tumors. A model for Cushing's disease.
    Helseth A; Siegal GP; Haug E; Bautch VL
    Am J Pathol; 1992 May; 140(5):1071-80. PubMed ID: 1316082
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Transgenic mice as animal model of Cushing's syndrome].
    Helseth A; Bautch VL; Haug E; Holm R; Nesland JM; Fodstad O
    Tidsskr Nor Laegeforen; 1993 Jan; 113(2):206-10. PubMed ID: 8381565
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endocrine and metabolic characteristics of polyoma large T transgenic mice that develop ACTH-producing pituitary tumors.
    Helseth A; Haug E; Nesland JM; Siegal GP; Fodstad O; Bautch VL
    J Neurosurg; 1995 May; 82(5):879-85. PubMed ID: 7714615
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies of ACTH secretion control in 116 cases of Cushing's syndrome.
    Raux MC; Binoux M; Luton JP; Gourmelen M; Girard F
    J Clin Endocrinol Metab; 1975 Feb; 40(2):186-97. PubMed ID: 163970
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bioactive and immunoreactive adrenocorticotropin in normal equine pituitary and in pituitary tumors of horses with Cushing's disease.
    Orth DN; Nicholson WE
    Endocrinology; 1982 Aug; 111(2):559-63. PubMed ID: 6284484
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibitory effects of SOM230 on adrenocorticotropic hormone production and corticotroph tumor cell proliferation in vitro and in vivo.
    Murasawa S; Kageyama K; Sugiyama A; Ishigame N; Niioka K; Suda T; Daimon M
    Mol Cell Endocrinol; 2014 Aug; 394(1-2):37-46. PubMed ID: 25011056
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathophysiology of Cushing's disease.
    Fehm HL; Voigt KH
    Pathobiol Annu; 1979; 9():225-55. PubMed ID: 225710
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biochemical assessment of Cushing's disease in patients with corticotroph macroadenomas.
    Katznelson L; Bogan JS; Trob JR; Schoenfeld DA; Hedley-Whyte ET; Hsu DW; Zervas NT; Swearingen B; Sleeper M; Klibanski A
    J Clin Endocrinol Metab; 1998 May; 83(5):1619-23. PubMed ID: 9589666
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Recent progress in experimental pituitary tumors in various animals].
    Ishii J; Kawakami Y
    Nihon Rinsho; 1993 Oct; 51(10):2580-4. PubMed ID: 8254925
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FSH-producing macroadenoma associated in a patient with Cushing's disease.
    Oyama K; Yamada S; Hukuhara N; Hiramatsu R; Taguchi M; Yazawa M; Matsuda A; Ohmura E; Imai Y
    Neuro Endocrinol Lett; 2006 Dec; 27(6):733-6. PubMed ID: 17187002
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transplantation of ACTH-secreting pituitary tumor cells in athymic nude mice.
    Leung CK; Paterson JA; Imai Y; Shiu RP
    Virchows Arch A Pathol Anat Histol; 1982 Aug; 396(3):303-12. PubMed ID: 6291229
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acquired prolactin deficiency (APD) after treatment for Cushing's disease is a reliable marker of irreversible severe GHD but does not reflect disease status.
    Mukherjee A; Murray RD; Teasdale GM; Shalet SM
    Clin Endocrinol (Oxf); 2004 Apr; 60(4):476-83. PubMed ID: 15049963
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Case report: bilateral Cushing's syndrome].
    Cheikhrouhou H; Khiari K; Chérif L; Ben Abdallah N; Ben Maïz H
    Tunis Med; 2003 Apr; 81(4):277-82. PubMed ID: 12848013
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A case of pituitary adrenocorticotropin-dependent Cushing's syndrome in the horse.
    Moore JN; Steiss J; Nicholson WE; Orth DN
    Endocrinology; 1979 Mar; 104(3):576-82. PubMed ID: 220013
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [CUSHING'S SYNDROME AND THE PITUITARY GLAND].
    IBAYASHI H
    Naika; 1964 Feb; 13():226-37. PubMed ID: 14137039
    [No Abstract]   [Full Text] [Related]  

  • 16. Plasma immunoreactive proopiomelanocortin peptides and cortisol in normal dogs and dogs with Addison's disease and Cushing's syndrome: basal concentrations.
    Peterson ME; Orth DN; Halmi NS; Zielinski AC; Davis DR; Chavez FT; Drucker WD
    Endocrinology; 1986 Aug; 119(2):720-30. PubMed ID: 3015556
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Different sensitivity to adrenocorticotropin of dispersed adrenocortical cells from patients with Cushing's disease with macronodular and diffuse adrenal hyperplasia.
    Lamberts SW; Bons EG; Bruining HA
    J Clin Endocrinol Metab; 1984 Jun; 58(6):1106-10. PubMed ID: 6327752
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adrenocorticotropin and cortisol hyperresponsiveness to hexarelin in patients with Cushing's disease bearing a pituitary microadenoma, but not in those with macroadenoma.
    Arvat E; Giordano R; Ramunni J; Arnaldi G; Colao A; Deghenghi R; Lombardi G; Mantero F; Camanni F; Ghigo E
    J Clin Endocrinol Metab; 1998 Dec; 83(12):4207-11. PubMed ID: 9851753
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thyrotropin-releasing hormone stimulation of adrenocorticotropin production by mouse pituitary tumor cells in culture: possible model for anomalous release of adrenocorticotropin by thyrotropin-releasing hormone in some patients with Cushing's disease and Nelson's syndrome.
    Gershengorn MC; Arevalo CO; Geras E; Rebecchi MJ
    J Clin Invest; 1980 Jun; 65(6):1294-300. PubMed ID: 6251109
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ACTH-producing pituitary tumors in transgenic mice. An ultrastructural and immunoelectron microscopic study.
    Holm R; Helseth A; Nesland JM; Bautch VL
    J Submicrosc Cytol Pathol; 1993 Jan; 25(1):29-36. PubMed ID: 8384929
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.